It is therefore not available as a licensed medicine through the NHS or private prescribing channels in the UK
In the SURPASS-2 trial, which compared it head-to-head against semaglutide 1 mg over 40 weeks, tirzepatide lowered HbA1c by about 2.0 to 2.3 percentage points across its 5, 10, and 15 mg doses, versus roughly 1.9 points for semaglutide, with greater weight loss as well
2 Wegovy (Semaglutide 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, & 2.4 mg) subcutaneous injection is an Rx only, helps to reduce excess body weight and maintain weight reduction in adults with obesity and adults with overweight and at least one weight-related condition
Underpinning all of this is a philosophy that respects curiosity and budget while celebrating variety